Skip to content
healthcare.dev
Get a free key

Remifentanil Hydrochloride

NDC 63323-725, Remifentanil Hydrochloride, injection, powder, lyophilized, for solution, from Fresenius Kabi USA, LLC.

Product NDC
63323-725
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206223
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63323-725 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • REMIFENTANIL HYDROCHLORIDE1 mg/mL

Pharmacologic classes

Full Opioid Agonists [MoA]; Opioid Agonist [EPC]

Package NDCNDC-11Package
63323-725-106332307251010 VIAL, SINGLE-DOSE in 1 CARTON (63323-725-10) / 10 mL in 1 VIAL, SINGLE-DOSE (63323-725-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d2374b84-81c9-44f9-a4a9-1071281b2531

Use it

Look up 63323-725 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63323-725 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63323-725. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.